• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[惊恐障碍的一年期转归]

[One-year outcome of panic disorder].

作者信息

Yoshimura Y, Miyaoka H, Ota A, Tatsumi M, Sakai T, Nozaki S, Kinami Y, Kamijima K

机构信息

Department of Psychiatry, Showa University School of Medicine.

出版信息

Seishin Shinkeigaku Zasshi. 1996;98(9):667-79.

PMID:8958757
Abstract

In this study we investigated the one-year outcome of panic disorder. The subjects were 169 panic disorder patients (69 males, 100 females; mean age 36.5 years), who attended the outpatient clinic of the Department of Psychiatry, Showa University Hospital, from September to December 1993. The outcome study was performed from October to December 1994. Patients who were being treated at Showa University Hospital during the outcome study were interviewed in person, and those who were not were interviewed by telephone. The one-year outcome of 100 patients (32 interviewed in person and 68 interviewed by telephone; 37 males, 63 females; mean age 39.5 years) was assessed. That of the remaining 69 patients was not assessed because they did not provide informed consent or had moved during the last year. The patients who were assessed (N = 100) were older and exhibited less severe phobic avoidance on their first visit to the clinic than those who were not assessed (N = 69). The frequency of panic attacks, and the severity of phobic avoidance and anticipatory anxiety decreased significantly between the time of the patients' first visit to the clinic and the time of the outcome study. Panic attacks, phobic avoidance and anticipatory anxiety disappeared in 27.0%, 32.9% and 13.6% and decreased in frequency or severity in 61.8%, 62.0% and 61.4% of the cases, respectively. Seventy-three patients felt that the severity of their panic disorder symptoms decreased between the time of the outcome study and the time of their first visit to the clinic, 20 felt that it had not changed and 7 felt that it had increased worse. The phobic avoidance and anticipatory anxiety at the time of the patients' first visit to the clinic were more severe, and the Global Assessment of Functioning Scale score was lower in the case of the former group of patients than in that of the latter two groups.

摘要

在本研究中,我们调查了惊恐障碍的一年期转归情况。研究对象为169例惊恐障碍患者(男性69例,女性100例;平均年龄36.5岁),他们于1993年9月至12月在昭和大学医院精神科门诊就诊。转归研究于1994年10月至12月进行。在转归研究期间仍在昭和大学医院接受治疗的患者接受了面对面访谈,未在该院治疗的患者则通过电话进行访谈。对100例患者(32例面对面访谈,68例电话访谈;男性37例,女性63例;平均年龄39.5岁)的一年期转归进行了评估。其余69例患者的转归未作评估,因为他们未提供知情同意或在过去一年中搬走了。接受评估的患者(N = 100)比未接受评估的患者(N = 69)年龄更大,且首次就诊时的恐惧回避症状较轻。在患者首次就诊至转归研究期间,惊恐发作的频率、恐惧回避及预期焦虑的严重程度均显著下降。惊恐发作、恐惧回避和预期焦虑分别在27.0%、32.9%和13.6%的病例中消失,在61.8%、62.0%和61.4%的病例中发作频率或严重程度降低。73例患者感觉其惊恐障碍症状的严重程度在转归研究时较首次就诊时有所减轻,20例感觉未变,7例感觉加重。前一组患者首次就诊时的恐惧回避和预期焦虑更严重,且功能总体评定量表评分低于后两组患者。

相似文献

1
[One-year outcome of panic disorder].[惊恐障碍的一年期转归]
Seishin Shinkeigaku Zasshi. 1996;98(9):667-79.
2
A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.一项关于文拉法辛缓释剂、帕罗西汀和安慰剂治疗惊恐障碍疗效的双盲研究。
Depress Anxiety. 2007;24(1):1-14. doi: 10.1002/da.20218.
3
Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.318例双相情感障碍患者的焦虑症:患病率及其对疾病严重程度和心境稳定剂反应的影响
J Clin Psychiatry. 2003 Mar;64(3):331-5.
4
Pretreatment anxiety level as differential predictor in outpatients with panic disorder.惊恐障碍门诊患者的治疗前焦虑水平作为差异预测指标
Arzneimittelforschung. 1992 Sep;42(9):1090-4.
5
[Panic disorder in the elderly].
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1998 Sep-Oct;26(5):297-301.
6
A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care.一项旨在提高基层医疗中惊恐障碍和广泛性焦虑障碍治疗质量的随机试验。
Arch Gen Psychiatry. 2005 Dec;62(12):1332-41. doi: 10.1001/archpsyc.62.12.1332.
7
[Intensive Naikan therapy for generalized anxiety disorder and panic disorder: clinical outcomes and background].[内观疗法强化治疗广泛性焦虑症和惊恐障碍:临床结果及背景]
Seishin Shinkeigaku Zasshi. 2005;107(7):641-66.
8
Anxiety sensitivity in social phobia: comparison between social phobics with and without panic attacks.社交恐惧症中的焦虑敏感性:有惊恐发作和无惊恐发作的社交恐惧症患者之间的比较。
Depress Anxiety. 2000;12(4):189-92. doi: 10.1002/1520-6394(2000)12:4<189::AID-DA1>3.0.CO;2-X.
9
Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.利培酮用于双相情感障碍焦虑症急性治疗的随机、安慰剂对照试验
J Affect Disord. 2009 Jun;115(3):376-85. doi: 10.1016/j.jad.2008.10.005. Epub 2008 Nov 29.
10
Personality disorders and response to medication treatment in panic disorder: a 1-year naturalistic study.惊恐障碍中的人格障碍与药物治疗反应:一项为期1年的自然主义研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1240-5. doi: 10.1016/j.pnpbp.2006.03.010. Epub 2006 May 6.